AndrewJosephAhmannMD

PubMed

• 248 citations
  Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
  S. Alice Long, Mary Rieck, Srinath Sanda, Jennifer B. Bollyky, Peter L. Samuels
  Diabetes. 2012-09-01
• 333 citations
  Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial*
  Andrew J. Ahmann, Matthew Capehorn, Guillaume Charpentier, Francesco Dotta, Elena Henkel
  Diabetes Care. 2017-12-15
• 59 citations
  T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
  Lawrence Fisher, Danielle Hessler, William H. Polonsky, Umesh Masharani, Susan Guzman
  Diabetes Care. 2018-09-01

Journal Articles

• T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults with Type 1 Diabetes  
  Sarah Kim, Umesh Masharani, Andrew Ahmann, William H Polonsky, Karen Weihs, Martha Shumway, Diabetes Care
• T1D Exchange Severe Hypoglycemia in Older Adults with Type 1 Diabetes Study Groups  
  Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Lilgenquist DR, Aleppo G, Buse JB, Kruger D, Bharga..., Diabetes Care, 1/1/2015
• Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study  
  Weiss R, Garg SK, Bode BW, Bailey TS, Ahmann AJ, Schultz KA, Welsh JB, Shin JJ., Diabetes Technol Ther, 1/1/2015
• Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-...  
  Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, Tornoe K, Boopalan A, Nauck MA, Diab Obes Metab, 1/1/2015
• Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaeneous Glucose Sensor  
  Bailey T, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh J, Lee S., Diabetes Technol Ther, 1/1/2014
• Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes  
  Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK, Diabetes Technol Ther, 1/1/2014
• Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)  
  Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson B..., Diabetes Technol Ther., 1/1/2013
• Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function  
  Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Blu..., Diabetes, 1/1/2012
• Rapamycin/ IL-2 combination therapy in type 1 diabetes augments Treg yet transiently impairs beta cell function  
  Long SA, Rieck M, Sanda S, BollyKy JB, Samuels RL, Goland R, Ahmann A, Rabinovitch A et al., Diabetes, 1/1/2012
• Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitus  
  Ahmann A., Am J Manag Care., 1/1/2011
• Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience  
  Buse JB, Dailey G, Ahmann AA, Bergenstal RM, Green JB, Peoples T, Tanenberg RJ, Yang Q., Diabetes Technol Ther., 1/1/2011
• Application of Compartive Effectiveness Research in Evaluation of Treaments for T2DM  
  Ahmann A, Am J Managed Care, 1/1/2011
• Baseline Predicors of A1c Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Theray: The STAR 3 Eperience  
  Buse JB, Dailey G, Ahmann A, Bergenstal RM, Green JB, Peoples MA, Tanenberg RJ, Yang Q., Diabetes Tech Ther, 1/1/2011
• Safety, pharmacokinetic profile, and metabolic effects of 14 days of treatment with DIO-902: results of a randomized, placebo-controlled randomized trial in patients w...  
  Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR, Clinical Therapeutics., 1/1/2008
• Managing the major complications of diabetes  
  Ahmann AJ, Comi R, Patient Care, 1/1/2004
• Analysis: Lessons on developing a better basal insulin  
  Ahmann A, Diabetes Technology and Therapeutics., 1/1/2004
• Technical Review: Management of Diabetes and Hyperglycemia in Hospitals  
  Clement S, Hirsch I, Ahmann AJ, Magee M, Braithwaite S, Smith P., Schafern, R., Hirsch, I., Diabetes Care., 1/1/2004
• Reduction of hospital costs and length of stay by good control of blood glucose levels  
  Ahmann, AJ., Endocrine Practice, 1/1/2004
• What to Do When Two Oral Agents Fail to Control Type 2 Diabetes – A Matter of Opinion or A Matter of Fact  
  Ahmann, AJ, Riddle MC, Am J Med, 1/1/2004
• Effects of a low fat diet compared to a high monounsaturated fat diet upon body weight, plasma lipids, lipoproteins, and glycemic control in type 2 diabetes  
  Gerhard GT, Ahmann A, Meeuws K, McMurry M, Duell PD, Conner WE, Am J. Clin Nutrition, 1/1/2004
• Current oral agents for type 2 diabetes  
  Ahmann AJ, Riddle MC, Postgraduate Medicine, 1/1/2002
• Diagnostic and Therapeutic Considerations in Adults with Diabetes Mellitus  
  Peters A, Ahmann AJ, and Rayburn K., J Clinical Outcomes Medicine, 1/1/1998
• A Comprehensive Approach to the Hospitalized Patient with Diabetes  
  The Endocrinologist., 1/1/1998
• Transcontinental Shipping of Pancreatic Islets for Auto-transplantation After Total Pancreatectomy  
  Rabkin JM, Leone JP, Sutherland DER, Ahmann AJ, Reed M, Paplois BE, Wahoff DC, Pancreas, 1/1/1997
• Endocrine-Metabolic Effects of Asthma Treatment: The Impact of Glucocorticoid Therapy in the Elderly  
  Ahmann AJ, Immunol Allergy Clin N.Am, 1/1/1997
• Join now to see all

Books/Book Chapters

• Insulin Therapy 
  Chapter: Insulin Therapy in Type 2 Diabetes Mellitus 
  Ahmann AJ, Riddle MCEditors: Leahy JL & Cafalu WT..Marcel Dekker, Inc.2002
• Conn’s Current Therapy 
  Chapter: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome 
  Ahmann AJ, Riddle MC.Editors: Rakel RE, Bope ET.W.B. Saunders Co.2001
• The Medical Management of Diabetes Mellitus. 
  Chapter: Oral Pharmacologic Agents in Type 2 Diabetes 
  Ahmann AJ, Riddle MC.Editors: Cefalu WT, Clark NG & Leahy JL..Marcel Dekker.2000
• Principles and Practices of Endocrinology and Metabolism 
  Chapter: The Thyroid Nodule. 
  Ahmann A, Wartofsky LEditors: Becker KL.J.B. Lippincott Co., Philadelphia1995
• Join now to see all

Abstracts/Posters

• A Comparison of Prandial Premixed (ILPS/Lispro) vs Basal Bolus (glargine/Lispro) Insulin Therapy in Obese Patinets with Type 2 Diabetes.
  Ahmann A, Jiang H, Martin S., Diabetes, 1/1/2008
• Hypoglycemia Rates with Titration of Prandial or Basal Bolus Insulin Therapy in Patients with Type 2 Diabetes
  Ahmann A, Jiang H, Martin SA., Diabetes, 1/1/2008
• Human Factors Assessment for Measuring Glucose Non-Invasively.
  Jovanovic L, Ahmann A, Edelman S, fischer J, Garg S, Monfre S, Ruchti T., Diabetes, 1/1/2007
• Metabolic Effects of 14-Day Treatment with DIO-902: Results of a Randomized Placebo-Controlled Trial in Patients with Type 2 Diabetes.
  Schwartz S, Rendell M, Ahmann A, Thomas A, Arauz-Pacheco C, Welles B., Diabetes, 1/1/2007
• Intenisive Insulin Therapy in Type 2 Diabetes (T2D) Patients Previously Treated with Glargine Plus Oral Agnets: Prandial NPL/Lispor Mixtures vs Glargine/ lispro Basal/...
  Rosentstock, J, Ahmann AJ, Colon G, Scism-Bacon JL, Jiang HH, Martin S., Diabetes, 1/1/2007
• Improved HbA1c levels through the use of an electronic logbook incorporating data displays: A multicenter, randomized, controlled trial.
  Hsu W, Laffel L, McGill BJ, Meneghini L, Kaiserman K, Donner T, Counts D, Ahmann A, Einhorn D., Diabetes, 1/1/2005
• Diabetes Management of Medicare patients Enrolled in Managed Care: A Patient Centered Analysis.
  Medak, R, Lucas J, Ahmann, AJ., Diabetes, 1/1/2003
• Serum Immunoglobulins in Patients with Graves Ophthalmopathy Directed against Unique Determinants of Porcine Eye Muscle.
  Ahmann AJ, Baker JR, Weetman AP, Wartofsky L, Nutman T, Burman KD., Annual Meeting American Federation for Clinical Research, Washington, DC, 1/1/1986
• Development of an Antigen-Responsive Intra Thyroidal T-Cell Population: Evidence that Thymocyte Antigens and OKT 3 T-Cell Receptor Mediate Cellular proliferation.
  Ahmann AJ, Baker JR, Wartofsky L, Burman KD., 61st Meeting of the American Thyroid Association, 1/1/1986
• Isolation of the Immune Response in Hashimoto’s Disease to Intrathyroidal Lymphocytes and the Production of Human Monoclinal Antibodies From there Lymphocytes.
  Baker JR, Saunders NB, Tseng YC, Wartofsky L, Ahmann AJ, Burman KD., 61st Meeting of the American Thyroid Association, 1/1/1986
• Evidence for Antibodies for Porcine Eye Muscle in Endocrine Ophthalmopathy
  Ahmann AJ, Baker JR, Wartofsky L, Weetman AP, Burman KD., Regional ACP meeting, San Francisco, CA, 1/1/1985
• Effects of Epidermal Growth Factor on Thyroglobulin and Cyclic AMP Production by Human Thyrocytes in Long-Term Culture.
  Tseng YL, Schaudies RP, Ahmann AJ, D’Avis J, Geelhoed GW, Burman KD, Wartofsky L., American Thyroid Association Meeting, Montreal, Canada, 1/1./1988
• Glucose Levels Assessed by Continuous Glucose Monitoring (CGM) across the Pediatric Age Range in Youth with Type 1 Diabetes (T1D).
  Laffel LM, Bailey TS, Ahmann AJ, Tsalikian E, Chase P, ADA 75th Scientific Sessions, Boston, MA, 1/5./2015
• Cholinergic Suppression TSH Secretion: Therapeutic Applications.
  Fein HG, Ahmann AJ, Hennessey JB, Butkus NE, Kornhauser DM, Petty BG, Smallridge RC., First International Congress of Neuroendocrinology, San Francisco, CA, 1/9./1986
• 2369-PO - Bolus Insulin Dosing and Nocturnal Hypoglycemia in the ASPIRE In-Home Study View session detail.
  Weiss R, Schwartz FL, Weinstock RS, Bode BW, Bailey T, Ahmann AJ, Kaufman F, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 331-OR - Efficacy and Safety of Liraglutide vs. Placebo When Added to Basal Insulin Analogs in Patients with Type 2 Diabetes (LIRA-ADD2BASAL)
  Ahmann AJ, Rodbard HW, Rosenstock J, Lahtela J, De Loredo L, Tornoe K, Boopalan A, Nauch MA., ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 231-OR - Hypoglycemia Reduction and Changes in A1C in the ASPIRE In-Home
  Bailey TS, Weiss R, Bode BW, Garg S, Ahmann AJ, Welsh JB, Lee SW, Aspire In-Home Study Group, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• A Human Monoclinal Antibody from Lymphocytes of a Patient with Graves Disease which Demonstrates Thyroid Stimulating Activity.
  Tseng YC, Baker JR, Saunders NA, Ahmann AJ, Burman KD, Wartofsky L., 69th Annual Endocrine Society Meeting., Indianapolis, IN, 1/9./1987
• Long-term Control of TSH-Secreting Macro Adenoma with a Somatostatin Analog (SMS 201-995).
  Smallridge RC, Ahmann AJ, Fein HG., 62nd American Thyroid Association Meeting, Washington DC, 1/16/1987
• Normal Bone Mineral Density in Premenopausal Women on Suppressive Doses of L-Thyroxine.
  Ahmann AJ, Solomon B, Duncan WE, Wartofsky L, American Thyroid Association Meeting, Washington DC, 1/16/1987
• 125-I Atriopeptin Binding to Cultured Procine Thyrocytes: Influenced of Iodine and Thyrotropin.
  Ahmann AJ, Tseng YL, Sellitti DF, Wartofsky L., 70th Annual Endocrine Society Meeting, New Orleans, LA, 1/8./1988
• Metformin+Exenatide+Basal Insulin vs Metformin+Placebo+Basal Insulin: Reaching A1c<6.5% Without Weight-Gain or Serious Hypoglycemia.
  Riddle M, Andrew A, Basu A, Vanita A, Ratner R, American Diabetes Association 70th Scientific Sessions, Orlando, FL, 1/25/2010
• Species-Specific and Age-Related Heterogeneity in 125-I ANP Binding to Thyroid Tissue.
  Ahmann AJ, Barnes S, Galloway R., 71st Annual Endocrine Society Meeting, Seattle, WA, 1/21/1989
• Low dose Metformin Added to Sulfonylures: Comparison of Two Regimens.
  Riddle MC, McDaniel PA, Mitchell ML, Ahmann AJ, Karl DM., International Society of Endocrinology, 1/12/1996
• 940-P - Time Spent (%) in Hypoglycemia Following Automatic Threshold Suspend Activation in the ASPIRE In-Home Study.
  Weiss R, Bailey TS, Schwartz FL, Garg S, Ahmann AJ, Thrasher J, Huang S, Lee SW, Aspire In-Home Study Group, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• Join now to see all

Lectures

• The Butterfly Effect: Resurrection of the Beta Cell in Type 2 Diabetes. 
  San Francisco, CA - 1/1/2007
• Recent Issues and Controversies in Diabetes Management 
  Eugene, OR - 1/6./2010
• The Big Picture: Perspectives On Diabetes 
  Portland, OR - 1/19/2007
• Perioperative Management of Diabetes 
  Portland, OR - 1/2./2007
• Update on New Insulin and Diabetes Therapies 
  Eugene, OR - 1/16/2007
• Case Studies In Type 1 Diabetes 
  Portland, OR - 1/28/2008
• Diabetes 2010 Update: What’s New & What’s True 
  Sacred Heart Medical Center, Eugene, OR - 1/12/2010
• Highlights of the Standards of Medical Care in Diabtes – 2010 
  Willamette Valley Medical Center, McMinville, OR - 1/29/2010
• Type 1 Diabetes Treatment for Primary Care 
  Governor Hotel, Portland, OR - 1/24/2012
• Prevention, Diagnosis and Initial Treatment of Type 2 Diabetes 
  Eugene, OR - 1/6./2010
• Re-evaluating Options In Treating Type 2 Diabetes 
  1/26/2007
• 2012 Clinical Practice Guidelines Update 
  1/8./2010
• Pharmacology Update 
  1/8./2010
• Class Dismissed: Your Take-Home Message 
  Grants Pass, OR - 1/29/2010
• Glucose Monitoring Guidelines and Caveats 
  Grants Pass, OR - 1/29/2010
• Diabetes Pathophysiology and Complications 
  Oregon State University School of Pharmacy - 1/26/2011
• Incretin Impairment and GLP-1: The Short Story 
  Samaritan Hospital, Lebanon, OR - 1/15/2011
• Diabetes Prevention: The Evidence 
  Portland, OR - 1/10/2015
• Biological Beta Cell Replacement: What you need to know when your patients ask 
  Ashland, OR - 1/1./2015
• Advanced Research in T2DM and Incretin Hormones 
  St. Vincent Medical Center, Portland, OR - 1/17/2006
• Inpatient Management of Hyperglycemia: Why All The Fuss 
  Portland, OR - 1/15/2004
• Glucose Control in the Surgical Patient 
  1/15/2005
• Management of Obesity 
  Vancouver, B.C. - 1/9./2005
• Treating Hyperglycemia in the Hospital 
  1/16/2005
• Catching the Wave: The New Emphasis on Improving Glucose Control in the Hospital. 
  Anchorage, Alaska - 1/15/2005
• Join now to see all

Other

• Designing and Implementing Insulin Infusion Protocols and Order Sets. 
  Ahmann A, Maynard G., J Hosp Med. (Online)
  1/1/2008
• Building and Implementing an Insulin Infusion Order Sets and Protocols In Workbook for Improvement: Improving Glycemic Control, Preventing Hypoglycemia, And Optimizing... 
  Ahmann A, Hellman R, Maynard G., Society of Hospital Medicine
  www.hospitalmedicine.org
  1/1/2007
• Guides Audio Poster Tour Moderator for Pharmacologic Treatment Of Diabetes – Novel Therapies. 
  American Diabetes Association Scientific Sessions
  San Diego, CA - 1/26/2011
• Focus On Inpatient Diabetes Management 
  American Association of Clinical Endocrinologists “Clinical Conversations”
  www.aace.com
  1/13/2007
• Improving Outcomes Through Glucose Control in the Hospital 
  VHA Live Televised CME Program
  Dallas, TX - 1/20/2005
• Join now to see all